Skip to main content

We are delighted to announce AGC Pharma Chemicals’ participation in BOS Basel, scheduled for June 19th to 20th in Basel, Switzerland.

BOS Basel’s scope is primarily development stage CMC outsourcing for Small Molecules. This means it offers a unique opportunity to connect with specialized experts and decision-makers in the field.

As a CDMO, at AGC Pharma Chemicals, we excel in providing comprehensive solutions for Small Molecules development and manufacturing. Our presence at BOS Basel will focus on our extensive experience in process development, scalable API life cycle management, and our state-of-the-art technology portfolio. We are dedicated to offering excellent, agile, and innovative processes, from raw material sourcing to final product delivery, ensuring your projects achieve success in a cost-effective manner.

Visit our booth 12 at BOS Basel to discover how we can enhance your biopharmaceutical projects with our approaches and expertise!

Latest News

All of ArticlesCDMO ProcessesThe Power of Small Particles: Understanding Micronization in Small Molecule APIs
26th June 2025

The Power of Small Particles: Understanding Micronization in Small Molecule APIs

Did you know that over 70% of new drug molecules face significant bioavailability challenges? The Paradigm Shift in Pharma With over 30% of active pharmaceutical ingredients (APIs) requiring micronization and…
NoticiasJun Kurihara new CEO of AGC Pharma Chemicals
4th June 2025

Jun Kurihara new CEO of AGC Pharma Chemicals

AGC Pharma Chemicals announces the appointment of Jun Kurihara as its new Chief Executive Officer, effective June 1, 2025. Kurihara, who currently serves as Executive Vice President, has extensive experience…
Events & ConventionsAGC Pharma Chemicals to join BOS Basel 2025
27th May 2025

AGC Pharma Chemicals to join BOS Basel 2025

AGC Pharma Chemicals is pleased to confirm its participation in BOS Basel 2025, taking place on June 11–12. This event, organized by Bio2Business, is a leading networking platform for biopharma…